Physical exercise during neoadjuvant chemotherapy for breast cancer as a mean to increase pathological complete response rates: Trial protocol of the randomized Neo-ACT trial

INTRODUCTION: In early breast cancer, neoadjuvant chemotherapy (NACT) is increasingly used. The proof of efficacy is pathologically complete response (pCR), i.e. the absence of invasive tumour in breast and lymph nodes at surgery. Today, pCR is a common endpoint in pharmaceutical trials since it is...

Descripción completa

Detalles Bibliográficos
Autores principales: de Boniface, Jana, Altena, Renske, Haddad Ringborg, Cecilia, Bolam, Kate A., Wengström, Yvonne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562167/
https://www.ncbi.nlm.nih.gov/pubmed/36227931
http://dx.doi.org/10.1371/journal.pone.0274804

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562167/
https://www.ncbi.nlm.nih.gov/pubmed/36227931
http://dx.doi.org/10.1371/journal.pone.0274804

Ejemplares similares